We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
Cap. Flow
-$1.48B
Cap. Flow %
-3.4%
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$364M
2
SIVB
SVB Financial Group
SIVB
+$155M
3
TXT icon
Textron
TXT
+$103M
4
TWTR
Twitter, Inc.
TWTR
+$102M
5
SNY icon
Sanofi
SNY
+$96.4M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$333M
2
XOM icon
ExxonMobil
XOM
+$242M
3
DLTR icon
Dollar Tree
DLTR
+$231M
4
NTR icon
Nutrien
NTR
+$213M
5
EYE icon
National Vision
EYE
+$198M

Sector Composition

Rank Sector Weight
1 Technology 22.53%
2 Healthcare 17.73%
3 Financials 14.85%
4 Consumer Discretionary 9.35%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCII
676
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$9.81M 0.02%
1,000,000
– –
PHM icon
677
Pultegroup
PHM
$25.1B
$9.81M 0.02%
247,500
-12,100
-5% -$510K
LOKM
678
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$9.8M 0.02%
1,000,000
– –
CPAR
679
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$9.75M 0.02%
1,000,000
– –
ASZ
680
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$9.75M 0.02%
1,000,000
– –
AUS
681
DELISTED
Austerlitz Acquisition Corporation I
AUS
$9.75M 0.02%
1,000,000
– –
TGNA
682
DELISTED
TEGNA Inc
TGNA
$9.61M 0.02%
+458,488
New +$9.93M
REG icon
683
Regency Centers
REG
$14.5B
$9.58M 0.02%
161,600
+700
+0.4% +$46.4K
ACLX
684
DELISTED
Arcellx
ACLX
$9.53M 0.02%
526,904
-400,664
-43% -$5.17M
NRG icon
685
NRG Energy
NRG
$24.7B
$9.43M 0.02%
+247,152
New +$10.1M
FE icon
686
FirstEnergy
FE
$27.9B
$9.39M 0.02%
244,600
-950,800
-80% -$40.6M
HZNP
687
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.37M 0.02%
117,500
-262,500
-69% -$24.9M
PANA
688
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$9.27M 0.02%
950,000
– –
BXP icon
689
Boston Properties
BXP
$11.3B
$9.14M 0.02%
102,758
-103,858
-50% -$11.5M
FOLD
690
DELISTED
Amicus Therapeutics
FOLD
$9.11M 0.02%
848,157
+298,157
+54% +$2.46M
NTLA icon
691
Intellia Therapeutics
NTLA
$1.58B
$9.11M 0.02%
175,978
+5,000
+3% +$254K
FTEV
692
DELISTED
FinTech Evolution Acquisition Group
FTEV
$9.06M 0.02%
925,000
– –
CHEAU
693
DELISTED
Chenghe Acquisition Co. Unit
CHEAU
$9.04M 0.02%
+900,000
New +$9.04M
SHUA
694
DELISTED
SHUAA Partners Acquisition Corp I Class A Ordinary Share
SHUA
$8.95M 0.02%
+900,000
New +$8.96M
WVE icon
695
Wave Life Sciences
WVE
$1.18B
$8.93M 0.02%
2,747,141
+2,297,141
+510% +$4.42M
FSBC icon
696
Five Star Bancorp
FSBC
$1.13B
$8.89M 0.02%
336,405
-35,868
-10% -$949K
B
697
Barrick Mining
B
$64B
$8.85M 0.02%
500,000
-6,100,000
-92% -$132M
SEE
698
DELISTED
Sealed Air
SEE
$8.78M 0.02%
152,175
-2,500
-2% -$158K
ACRS icon
699
Aclaris Therapeutics
ACRS
$835M
$8.72M 0.02%
625,000
+200,000
+47% +$2.8M
EG icon
700
Everest Group
EG
$14.2B
$8.71M 0.02%
31,081
-10,000
-24% -$2.83M
26 27
28
29 30

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.

  • Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
  • Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
  • Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
  • Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
  • Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
  • Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.